The first potent small molecule sst2 antagonists are reported. Altering kno
wn sst2 agonist molecules yielded compounds with high sst2 binding affinity
and full antagonist activity. Compound 7a, for example, displaced somatost
atin binding to the sst2 receptor with an IC50 = 2.9 nM and antagonized som
atostatin action with an IC50 = 29 nM. (C) 2001 Elsevier Science Ltd. All r
ights reserved.